21
May
2018
|
17:33
Europe/Amsterdam

Progress in stem cell treatment offers new hope

A research team from the Dept of Pharmacy at NUS Faculty of Science, Duke-NUS Medical School, National Cancer Centre Singapore and Singapore General Hospital found that a laboratory-synthesised chemical substance called C7 can be used to increase the number of stem cells harvested from umbilical cords. This will help overcome a current challenge of cell levels being too low to help patients recover.